Purchase Short-Term Access

Tiotropium reduced exacerbations but not rate of FEV₁ decline in patients with COPD using other respiratory medications

Matthew B. Stanbrook, MD, PhD

Annals of Internal Medicine 2009;150:JC1-7. doi:10.7326/0003-4819-150-2-200901200-02007

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)